Henry Erlich | Oct 30, 1988 | 4 min read
In recent years, the clinical diagnosis of genetic and infectious dis- eases has relied on the analysis of specific DNA nucleotide sequences. And for molecular biolo gists, the task of finding a particular target strand, only a minute fraction of the total DNA, has been a burdensome challenge—like searching for a needle in a haystack. Now, however, GeneAmp PCR, a product based on proprietary technology of Cetus Corp., Emeryville, Calif., not only helps scientists find that one needle in